Skip to content

Safety, popularization and application of distal radial artery approach in the diagnosis and treatment of cerebrovascular diseases

Risk analysis of perioperative radial artery occlusion in symptomatic cerebrovascular disease with distal radial or traditional radial approach: a prospective, single-center, case-control study - RAO-dTRA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064243
Enrollment
Unknown
Registered
2022-10-01
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovascular disease

Interventions

dTRA group:Puncture the distal radial artery
conventional transradial approach:Puncture the proximal radial artery

Sponsors

Department of Neurosurgery, Shanghai East Hospital, School of Medicine, Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >18 years old <80 years old, male or non-pregnant female; 2. Patients with cerebrovascular disease who are eligible for cerebral angiography or interventional therapy; 3. Expected survival period ? 3 months; 4. The function of major organs is normal; 5. The subjects are willing to join the study, sign the informed consent form, have good compliance, and cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: 1. Severe radial artery, brachial artery, subclavian artery, brachiocephalic artery, iliac artery, or common femoral artery stenosis, determined by physical examination and ultrasonography that may obstruct the passage of the guide wire; unpalpable radial artery or negative; 2. Contraindications for angiography, such as severe heart, lung, or kidney disease; those who are allergic to or intolerable to contrast media; those who cannot keep supine for a long time; those who have abnormal coagulation function and have a tendency to bleeding; 3. Investigators believe that they are not suitable for inclusion: women who are pregnant and breastfeeding; patients who have recently received radial artery access for diagnosis and treatment; those who have participated in clinical trials of other drugs or medical devices before enrollment but did not reach the primary study endpoint time limit; 4. Ruptured aneurysm (patients with Hunt-Hess>3) or combined with large intracranial hematoma may be life-threatening; 5. Patients who were admitted and discharged within 24 hours, those who could not complete the ultrasound examination and those who refused ultrasound follow-up; 6. Patients who cannot receive antiplatelet aggregation or anticoagulation therapy; 7. The investigators believe that patients who are not suitable to participate in or continue to participate in this clinical trial or patients who automatically withdraw from the protocol in the middle of the trial.

Design outcomes

Primary

MeasureTime frame
radial artery occlusion;

Secondary

MeasureTime frame
Sheath insertion success rate;total fluoroscopy time;number of crossovers;

Countries

China

Contacts

Public ContactKaijun Zhao

Shanghai East Hospital, School of Medicine, Tongji University

zkjwcfzwh@163.com+86 13482037848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026